Navigation path

For an easy-to-read introduction to FP7 in 21 languages, see the brochure, "FP7 - tomorrow's answers
start today", on Understanding the Seventh Framework Programme

 

FP7 was the European Union's Research and Innovation
funding programme for 2007-2013.
The current programme is Horizon 2020
but there are many projects funded under FP7 which are still running.


ERA-NET projects - what people are saying

Projects home page | Testimonials | Project list |  Videos |  News  

Máire GEOGHEGAN-QUINN
Commissioner for Research,
Innovation and Science
“Thinking European is vital in making 'research to retail' happen. Since 2002 over €2 billion has been spent by programme managers and owners investing jointly in coordinated research across borders. Such jointly-funded research also improves our quality of life and demonstrates the effectiveness of working together.
Take infectious diseases. They don't respect national boundaries so neither should we in our efforts to tackle them! Thanks to the work by EU funded researchers, some 287 genes have been uncovered as being involved in the spread of viruses. Important research, especially when we remember the recent risks of diseases like swine flu (H1N1) and bird flu (H5N1). Through funding from the ERA-NET Pathogenomics project these researchers are working together to find ways of protecting us from any future possible pandemics.”
Juan Tomas HERNANI
Secretary General for Innovation
Government of Spain
“ERA-NET has created a fabulous mobilisation of European civil servants towards the consciousness and the need for connection between programmes. Hundreds of European SMEs have started to work and participate in ERA through these national and regional programmes. We are thankful to the visionaries of the early 2000s who launched the initiative, and to the champions that managed the best networks, demonstrating to all of us that this coordination was more than possible, it is a necessity for our programs.
The challenge is now to define a simple schema for the next ten years, which will take the best out of this successful story, and will address fragmentation issues that already require a bold response.”  
Manfred HORVAT  Chairman of the ERA-NET Expert Review Group 2006
“The ERA-NET scheme showed in an impressive way that there are important opportunities and synergies for research at European level also beyond the EU RTD Framework Programme. This is empirical evidence most relevant for the further development of ERA as a truly integrated market for research, technological development – and innovation!
On the other side, the review and evaluation exercises of the ERA-NET scheme showed that for the future common framework conditions for national and European research promotion and funding have to be developed in a joint effort of the member states in order to ensure efficiency and effectiveness of ERA and, thus, the emerging European research and innovation system.
The ERA-NET scheme presents an important precursor and testing platform for the forthcoming Joint Programming activities that will open a new phase for European RTD and that will further strengthen Europe’s position in the new global landscape of knowledge creation and innovation.”
Stavros KATSANEVAS
Professor of University Paris 7 “Denis Diderot”
Deputy Scientific Director of the French National Institute of Nuclear and Particle Physics  (IN2P3/CNRS)
Coordinator of  ERA-NET ASPERA (2006-2009)
(photo: © IPMU)
“Ours is an interdisciplinary field of fundamental science; as its name Astroparticle suggests, it is at the frontier of particle physics and astrophysics. In many countries its funding used to fall between disciplinary “cracks” while its themes of research made scientists to work in widely different experimental settings: from the desert to the bottom of the sea or from underground laboratories to space satellites. ASPERA created a sense of community for the scientists and the agencies implicated and above all a common vision for the future.
We dubbed the priority infrastructures of our roadmap the “Magnificent Seven”, and ever since we are working on the funding and legal mechanisms for their realisation; two of them entered the ESFRI priority list. The example of European convergence on a small set of priorities impressed our partners in other continents, and there is now a working group of the OECD Global Science Forum, attempting to repeat the successful European coordination of Astroparticle Physics on a global scale.
Last but not least, ASPERA set the agenda for the creation of a more sustainable coordination of the field in Europe, pursued in ASPERA-2 and ApPEC the consortium of European agencies that initiated ASPERA.”
Imelda LAMBKIN National Director for FP7 Enterprise Ireland
“Sustained national investments in research and innovation position Europe’s Member States to engage in a meaningful way on the world stage. As individual countries, we use international networks in outward-looking national strategies that place particular emphasis on the visibility of our research systems and international recognition of our capacity to innovate, to really succeed. The European Research Area coordination instruments provide one route to doing so by creating broadly-based networks in particular scientific and technological domains.
As the evidence of the strengthening of the European base (the European Research Area) through these activities grows, it is essential that we continue to invest our time and resources in them with a particular focus on meeting societal needs and the needs of the enterprise sector.”
Maja RUPNIK, PhD
Head of Research department, Center for Microbiology, Institute of Public Health Maribor, Maribor, Slovenia
and
Head of Department for Microbiology, Faculty of Medicine, University of Maribor, Maribor, Slovenia
(NB: reproduction of the photograph is not authorised)
“Being a member of ERA-NET Pathogenomics research community has several advantages especially for a research group from such a small country as Slovenia. Application and follow-up of projects is relatively simple and one is a part of larger research community with similar research interest, namely pathogenesis and genomics, yet different methods, microbes and techniques. Either though participation in two projects or during regular yearly Progress seminars for all ERA NET Pathogenomics partners we have established many new contacts and collaborations.
Comparing my experience with ERA-NET Pathogenomics and other different EU grants I believe that ERA-NETs are one of the best ways of support for European research community at least in project types of certain size.”

 

Related sites